InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,519.27
(
0.19%
)
US TECH 100
19,494.00
(
0.08%
)
Dow Jones
39,357.05
(
0.06%
)
Brent Oil
86.47
(
0.02%
)
Bitcoin
60,422.56
(
-2.59%
)
Post# of 252468
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 87289

Tuesday, 06/29/2010 5:15:43 AM

Tuesday, June 29, 2010 5:15:43 AM

Post# of 252468
The FDA approved Venlafaxine HCl ER Capsules, Teva's generic version of Wyeth's antidepressant Effexor XR®. Shipment is expected to commence on July 1, 2010, as per the terms of the 2006 agreement with Wyeth.

As the first company to file an Abbreviated New Drug Application (ANDA) containing a paragraph IV certification for this product, Teva has been awarded a 180-day period of marketing exclusivity.

The brand product had annual sales of approximately $2.75 billion in the United States, based on IMS sales data.

http://www.tevapharm.com/pr/2010/pr_945.asp
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up